Gapping down
In reaction to disappointing earnings/guidance:
- N/A.
Other news:
- RTTR -26.5% (prices $23,000,000 offering)
- YUMA -9.6% (upsizes common stock offering and prices the 9.6 mln shares at $1/share)
- PRTA -5.5% (announces results of a Phase 1b study of PRX003 in patients with psoriasis were insufficient to advance PRX003 into mid-stage clinical development)
- NITE -4.3% (modestly pulling back from today's 10 point surge higher)
- GLYC -4.1% (files for $250 mln mixed securities shelf offering ; entered $100 mln common stock Sales Agreement with Cowen via at the market offering)
- PE -2% (reaffirms production volume guidance and defers anticipated non-operated development activity; postponements reduce estimated 3Q17 and 4Q17 production by ~1.5 MBoe per day and 2.0 MBoe per day, respectively)
- NXST -1.1% (hearing block trade pricing)
- CSGP -0.7% (priced offering of 2,884,616 shares of common stock at $260.00 per share)
- HLT -0.6% (prices secondary offering of 14.61 mln shares of common stock by selling stockholders affiliated with The Blackstone Group)
Analyst comments:
- LKSD -3% (downgraded to Sell from Neutral at Citigroup)